---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-009420"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2022-04-18T23:59:59+00:00"
generated_at: "2026-06-26T06:50:05.916835+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ChromaDex announces director retirement and appointment of two new independent directors

## Summary
- Stephen Block to retire from board at 2022 annual meeting; not due to any disagreement.
- Kristin Patrick appointed to board and Nominating Committee; currently EVP/CMO of Claires, Inc.
- Ann Cohen appointed to board and Audit Committee; EVP/CFO of The Institute of Internal Auditors, CPA.
- Each new director receives 40,000 stock option grant vesting over 3 years, plus annual retainer of $40,000.

## SEC filing metadata
- accession: 0001628280-22-009420
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2022-04-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/0001628280-22-009420-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/cdxc-20220414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-009420
- JSON: https://secwatch.observer/filing/0001628280-22-009420.json
- Plain text: https://secwatch.observer/filing/0001628280-22-009420.txt

## Key facts
- Executive change
  Ann Cohen was appointed as Director at Niagen Bioscience, Inc..
  - Action: appointed
  - Role: Director
  source text: On April 15, 2022, the Board appointed each of Kristin Patrick and Ann Cohen as a member of the Board effective as of such date, to serve until the Company’s Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/0001628280-22-009420-index.htm
- Executive change
  Kristin Patrick was appointed as Director at Niagen Bioscience, Inc..
  - Action: appointed
  - Role: Director
  source text: On April 15, 2022, the Board appointed each of Kristin Patrick and Ann Cohen as a member of the Board effective as of such date, to serve until the Company’s Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/0001628280-22-009420-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.